Derivation and immunological characterization of mesenchymal stromal cells from human embryonic stem cells

Experimental Hematology

Volumn 36, Issue 3, 2008, Pages 350-359

  Trivedi, Parul ^a   Hematti, Peiman ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MARKER; CELL SURFACE MARKER; GAMMA INTERFERON; HLA ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA DR ANTIGEN; MATRIGEL;

ARTICLE; BONE MARROW; CELL CULTURE; CELL DIFFERENTIATION; CELL LINE; CELL LINEAGE; CELL POPULATION; CELL PROLIFERATION; CELL STRUCTURE; CELL SURFACE; COCULTURE; CONTROLLED STUDY; EMBRYONIC STEM CELL; FIBROBLAST; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; MIXED LYMPHOCYTE REACTION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; EMBRYONIC STEM CELLS; FLOW CYTOMETRY; HLA ANTIGENS; HUMANS; INTERFERON TYPE II; LEUKOCYTES, MONONUCLEAR; MESENCHYMAL STEM CELLS; STROMAL CELLS; T-LYMPHOCYTES;

MURINAE;

EID: 39149141866     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2007.10.007     Document Type: Article

References (44)

1. Friedenstein A.J., Chailakhyan R.K., Latsinik N.V., Panasyuk A.F., and Keiliss-Borok I.V. Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation 17 (1974) 331-340
2. Caplan A.I. Mesenchymal stem cells. J Orthop Res 9 (1991) 641-650
3. Pittenger M.F., Mackay A.M., Beck S.C., et al. Multilineage potential of adult human mesenchymal stem cells. Science 284 (1999) 143-147
4. Javazon E.H., Beggs K.J., and Flake A.W. Mesenchymal stem cells: paradoxes of passaging. Exp Hematol 32 (2004) 414-425
5. Seeberger K.L., Dufour J.M., Shapiro A.M., Lakey J.R., Rajotte R.V., and Korbutt G.S. Expansion of mesenchymal stem cells from human pancreatic ductal epithelium. Lab Invest 86 (2006) 141-153
6. Sabatini F., Petecchia L., Tavian M., Jodon de Villeroche V., Rossi G.A., and Brouty-Boye D. Human bronchial fibroblasts exhibit a mesenchymal stem cell phenotype and multilineage differentiating potentialities. Lab Invest 85 (2005) 962-971
7. da Silva Meirelles L., Chagastelles P.C., and Nardi N.B. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 119 (2006) 2204-2213
8. Campagnoli C., Roberts I.A., Kumar S., Bennett P.R., Bellantuono I., and Fisk N.M. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 98 (2001) 2396-2402
9. in 't Anker P.S., Noort W.A., Scherjon S.A., et al. Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential. Haematologica 88 (2003) 845-852
10. Wang G., Bunnell B.A., Painter R.G., et al. Adult stem cells from bone marrow stroma differentiate into airway epithelial cells: potential therapy for cystic fibrosis. Proc Natl Acad Sci U S A 102 (2005) 186-191
11. Grove J.E., Bruscia E., and Krause D.S. Plasticity of bone marrow-derived stem cells. Stem Cells 22 (2004) 48-7500
12. Jiang Y., Jahagirdar B.N., Reinhardt R.L., et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418 (2002) 41-49
13. Le Blanc K., and Ringden O. Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 11 (2005) 321-334
14. Bartholomew A., Sturgeon C., Siatskas M., et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 30 (2002) 42-48
15. Aggarwal S., and Pittenger M.F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105 (2005) 1815-1822
16. Tse W.T., Pendleton J.D., Beyer W.M., Egalka M.C., and Guinan E.C. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 75 (2003) 389-397
17. Olivier E.N., Rybicki A.C., and Bouhassira E.E. Differentiation of human embryonic stem cells into bipotent mesenchymal stem cells. Stem Cells 24 (2006) 1914-1922
18. Lian Q., Lye E., Yeo K.S., et al. Derivation of clinically compliant MSCs from CD105+. Stem Cells 25 (2007) 425-436
19. Trivedi P., and Hematti P. Simultaneous generation of CD34(+) primitive hematopoietic cells and CD73(+) mesenchymal stem cells from human embryonic stem cells cocultured with murine OP9 stromal cells. Exp Hematol 35 (2007) 146-154
20. Barberi T., Willis L.M., Socci N.D., and Studer L. Derivation of multipotent mesenchymal precursors from human embryonic stem cells. PLoS Med 2 (2005) e161
21. Plumas J., Chaperot L., Richard M.J., Molens J.P., Bensa J.C., and Favrot M.C. Mesenchymal stem cells induce apoptosis of activated T cells. Leukemia 19 (2005) 1597-1604
22. Dominici M., Le B.K., Mueller I., et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8 (2006) 315-317
23. Xu C., Jiang J., Sottile V., McWhir J., Lebkowski J., and Carpenter M.K. Immortalized fibroblast-like cells derived from human embryonic stem cells support undifferentiated cell growth. Stem Cells 22 (2004) 972-980
24. Stojkovic P., Lako M., Stewart R., et al. An autogeneic feeder cell system that efficiently supports growth of undifferentiated human embryonic stem cells. Stem Cells 23 (2005) 306-314
25. Wang Q., Fang Z.F., Jin F., Lu Y., Gai H., and Sheng H.Z. Derivation and growing human embryonic stem cells on feeders derived from themselves. Stem Cells 23 (2005) 1221-1227
26. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., et al. Embryonic stem cell lines derived from human blastocysts. Science 282 (1998) 1145-1147
27. Wagner W., Wein F., Seckinger A., et al. Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp Hematol 33 (2005) 1402-1416
28. Cheng L., Hammond H., Ye Z., Zhan X., and Dravid G. Human adult marrow cells support prolonged expansion of human embryonic stem cells in culture. Stem Cells 21 (2003) 131-142
29. Gang E.J., Bosnakovski D., Figueiredo C.A., Visser J.W., and Perlingeiro R.C. SSEA-4 identifies mesenchymal stem cells from bone marrow. Blood 109 (2007) 1743-1751
30. Battula V.L., Bareiss P.M., Treml S., et al. Human placenta and bone marrow derived MSC cultured in serum-free, b-FGF-containing medium express cell surface frizzled-9 and SSEA-4 and give rise to multilineage differentiation. Differentiation 75 (2007) 279-291
31. Shibata H., Ageyama N., Tanaka Y., et al. Improved safety of hematopoietic transplantation with monkey embryonic stem cells in the allogeneic setting. Stem Cells 24 (2006) 1450-1457
32. Le Blanc K., Tammik C., Rosendahl K., Zetterberg E., and Ringden O. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 31 (2003) 890-896
33. Di Nicola M., Carlo-Stella C., Magni M., et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99 (2002) 3838-3843
34. Prockop D.J., Gregory C.A., and Spees J.L. One strategy for cell and gene therapy: harnessing the power of adult stem cells to repair tissues. Proc Natl Acad Sci U S A 100 Suppl 1 (2003) 11917-11923
35. Lee R.H., Seo M.J., Reger R.L., et al. Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proc Natl Acad Sci U S A 103 (2006) 17438-17443
36. Giordano A., Galderisi U., and Marino I.R. From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells. J Cell Physiol 211 (2007) 27-35
37. Lazarus H.M., Koc O.N., Devine S.M., et al. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant 11 (2005) 389-398
38. Koc O.N., Gerson S.L., Cooper B.W., et al. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol 18 (2000) 307-316
39. Horwitz E.M., Prockop D.J., Gordon P.L., et al. Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta. Blood 97 (2001) 1227-1231
40. Koc O.N., Day J., Nieder M., Gerson S.L., Lazarus H.M., and Krivit W. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant 30 (2002) 215-222
41. Chen S.L., Fang W.W., Ye F., et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 94 (2004) 92-95
42. Le Blanc K., and Pittenger M. Mesenchymal stem cells: progress toward promise. Cytotherapy 7 (2005) 36-45
43. Ringden O., Uzunel M., Rasmusson I., et al. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 81 (2006) 1390-1397
44. Taupin P. OTI-010 Osiris Therapeutics/JCR Pharmaceuticals. Curr Opin Investig Drugs 7 (2006) 473-481